Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities

COVID-19, a significant global health threat, appears to be an immune-related disease. Failure of effective immune responses in initial stages of infection may contribute to development of cytokine storm and systemic inflammation with organ damage, leading to poor clinical outcomes. Disease severity...

Full description

Bibliographic Details
Main Authors: Zuzana Nova, Tomas Zemanek, Norbert Botek
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/23/15122
_version_ 1797463059300614144
author Zuzana Nova
Tomas Zemanek
Norbert Botek
author_facet Zuzana Nova
Tomas Zemanek
Norbert Botek
author_sort Zuzana Nova
collection DOAJ
description COVID-19, a significant global health threat, appears to be an immune-related disease. Failure of effective immune responses in initial stages of infection may contribute to development of cytokine storm and systemic inflammation with organ damage, leading to poor clinical outcomes. Disease severity and the emergence of new SARS-CoV-2 variants highlight the need for new preventative and therapeutic strategies to protect the immunocompromised population. Available data indicate that these people may benefit from adoptive transfer of allogeneic SARS-CoV-2-specific T cells isolated from convalescent individuals. This review first provides an insight into the mechanism of cytokine storm development, as it is directly related to the exhaustion of T cell population, essential for viral clearance and long-term antiviral immunity. Next, we describe virus-specific T lymphocytes as a promising and efficient approach for the treatment and prevention of severe COVID-19. Furthermore, other potential cell-based therapies, including natural killer cells, regulatory T cells and mesenchymal stem cells are mentioned. Additionally, we discuss fast and effective ways of producing clinical-grade antigen-specific T cells which can be cryopreserved and serve as an effective “off-the-shelf” approach for rapid treatment of SARS-CoV-2 infection in case of sudden patient deterioration.
first_indexed 2024-03-09T17:45:20Z
format Article
id doaj.art-393ca570070d4d459ed385cbdb8afa91
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T17:45:20Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-393ca570070d4d459ed385cbdb8afa912023-11-24T11:13:38ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-12-0123231512210.3390/ijms232315122Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future PossibilitiesZuzana Nova0Tomas Zemanek1Norbert Botek2Lambda Life a.s., Levocska 3617/3, 851 01 Bratislava, SlovakiaLambda Life a.s., Levocska 3617/3, 851 01 Bratislava, SlovakiaLambda Life a.s., Levocska 3617/3, 851 01 Bratislava, SlovakiaCOVID-19, a significant global health threat, appears to be an immune-related disease. Failure of effective immune responses in initial stages of infection may contribute to development of cytokine storm and systemic inflammation with organ damage, leading to poor clinical outcomes. Disease severity and the emergence of new SARS-CoV-2 variants highlight the need for new preventative and therapeutic strategies to protect the immunocompromised population. Available data indicate that these people may benefit from adoptive transfer of allogeneic SARS-CoV-2-specific T cells isolated from convalescent individuals. This review first provides an insight into the mechanism of cytokine storm development, as it is directly related to the exhaustion of T cell population, essential for viral clearance and long-term antiviral immunity. Next, we describe virus-specific T lymphocytes as a promising and efficient approach for the treatment and prevention of severe COVID-19. Furthermore, other potential cell-based therapies, including natural killer cells, regulatory T cells and mesenchymal stem cells are mentioned. Additionally, we discuss fast and effective ways of producing clinical-grade antigen-specific T cells which can be cryopreserved and serve as an effective “off-the-shelf” approach for rapid treatment of SARS-CoV-2 infection in case of sudden patient deterioration.https://www.mdpi.com/1422-0067/23/23/15122COVID-19severe acute respiratory syndrome coronavirus 2virus-specific T cellscellular therapiesimmunotherapy
spellingShingle Zuzana Nova
Tomas Zemanek
Norbert Botek
Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities
International Journal of Molecular Sciences
COVID-19
severe acute respiratory syndrome coronavirus 2
virus-specific T cells
cellular therapies
immunotherapy
title Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities
title_full Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities
title_fullStr Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities
title_full_unstemmed Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities
title_short Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities
title_sort antigen specific t cells and sars cov 2 infection current approaches and future possibilities
topic COVID-19
severe acute respiratory syndrome coronavirus 2
virus-specific T cells
cellular therapies
immunotherapy
url https://www.mdpi.com/1422-0067/23/23/15122
work_keys_str_mv AT zuzananova antigenspecifictcellsandsarscov2infectioncurrentapproachesandfuturepossibilities
AT tomaszemanek antigenspecifictcellsandsarscov2infectioncurrentapproachesandfuturepossibilities
AT norbertbotek antigenspecifictcellsandsarscov2infectioncurrentapproachesandfuturepossibilities